Anemia risk and outcomes in newborns
Part of Blood & lymphatic, Genetic & congenital, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study looks at why some newborns develop anemia (low red blood cells) and how it affects their health in the NICU. It aims to find better ways to care for babies with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be a newborn admitted to the NICU within the first 24 hours of life.
- Your baby can be born at full term or prematurely.
- Your baby must not have any major birth defects (congenital malformations).
- Your baby must not have a chromosomal abnormality or a genetic syndrome.
- Your baby must not have received a blood transfusion before joining the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two simple blood tests (CBC and lactate) in newborns with signs of infection. These tests may help doctors find sepsis faster and guide treatment.
This study looks at a specific blood protein level in children from birth to age 17. It compares healthy children and those with sepsis to see if the protein changes during infection.
This study looks at how sepsis (a serious infection in the blood) affects the brain and nervous system in newborns. Doctors will check babies for signs of brain or nerve problems to better understand and care for them.
This study looks at whether different levels of hemoglobin (the part of blood that carries oxygen) in pregnant women affect the health of the mother and baby around birth. It aims to find if certain levels are better or worse for outcomes.
This study is looking at a new way to detect bleeding between the mother and baby during pregnancy (called fetomaternal hemorrhage), which can lead to a blood problem in the newborn called hemolytic disease. The goal is to see if this test can help diagnose the condition earlier and hopefully improve care for the baby.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.